Roche Diagnostics Australia to welcome new leadership in international promotion

Diagnostics & MedTech News: Set to assume the role of Managing Director of Roche Diagnostics Australia in the coming months is the current Global Head of Solutions Marketing and Roche Academy, Anand Vairavan, who will be making an international transfer to take on this new leadership position.

Vairavan will succeed Allison Rossiter, who is set to become the CEO of the homegrown infectious disease company, Genetic Signatures, effective September 30. This transition concludes Rossiter’s notable 22-year tenure with Roche Diagnostics Australia.

Vairavan brings a wealth of experience to his new role, having held senior marketing and commercial positions at Roche, Novartis, and AutoGenomics. He has accumulated over eight years at Roche, showcasing exceptional leadership and strategic vision in senior marketing roles.

In related news, Roche Diagnostics has announced a new commercial partnership with Abacus dx. This collaboration will see Abacus dx handling the Australian distribution of Roche’s molecular diagnostics hardware and reagents.

Key products in this distribution agreement include the LightCycler 96 System, LightCycler 480 II System, MagNA Pure 24 System, and MagNA Pure 96 System. Additionally, Abacus dx will distribute Roche’s advanced tissue diagnostics solutions, such as the Ventana Discovery Ultra and a comprehensive suite of Sequencing Solutions reagents.

This commercial partnership unites Abacus dx’s extensive distribution network with Roche’s innovative solutions for the Australian healthcare sector.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.